Evaluating the likelihood of pediatric sacral nerve stimulator explantations due to cure or complications: a survival analysis of 13-year institutional cohort
Approximately quarter of children with SNM placement achieved cure with increasing probability with follow-up time. More than 70% of explantations are due to cure and less than 10% were due to infections. There is high likelihood of sustained symptom resolution following explantation for cure. SNM remains a safe and viable option for children with refractory BBD with potential for cure.
Authors
- Kirstan K. Meldrum (ORCID: https://orcid.org/0000-0002-8165-3745)
- Benjamin Whittam (ORCID: https://orcid.org/0000-0001-6881-5706)
- Joshua Roth
- Martin Kaefer (ORCID: https://orcid.org/0000-0003-4362-8116)
- Rosalia Misseri (ORCID: https://orcid.org/0000-0001-6638-3858)
- Richard C. Rink (ORCID: https://orcid.org/0000-0003-4265-5577)
- Nikhil V. Batra (ORCID: https://orcid.org/0000-0003-0763-5466)
- Konrad M. Szymanski (ORCID: https://orcid.org/0000-0001-7087-8968)
- Pankaj Dangle (ORCID: https://orcid.org/0000-0002-8097-044X)
- Jin K. Kim (ORCID: https://orcid.org/0000-0003-0964-9503)
- Mark P. Cain
- Shelly King
Institutions
- Riley Hospital for Children (US)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1007/s00345-025-05916-7
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.84